Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. (Q50560812)
Jump to navigation
Jump to search
scientific article published in April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. |
scientific article published in April 2010 |
Statements
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. (English)
1 reference
Patrick Marcellin
1 reference
Michelle Martinot-Peignoux
1 reference
Christiane Stern
1 reference
Sarah Maylin
1 reference
Marie-Pierre Ripault
1 reference
Nathalie Boyer
1 reference
Laurence Leclere
1 reference
Corinne Castelnau
1 reference
Nathalie Giuily
1 reference
Ahmed El Ray
1 reference
Ana-Carolina Cardoso
1 reference
Rami Moucari
1 reference
Tarik Asselah
1 reference
1 April 2010
1 reference
51
1 reference
4
1 reference
1122-1126
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference